J Korean Ophthalmol Soc > Volume 58(1); 2017 > Article
Journal of the Korean Ophthalmological Society 2017;58(1):93-97.
DOI: https://doi.org/10.3341/jkos.2017.58.1.93    Published online January 15, 2017.
A Case of Retinal Hemorrhage Following a Dexamethasone Intravitreal Implant.
Min Hwan Kim, Young Hoon Lee
Department of Ophthalmology, Konyang University College of Medicine, Daejeon, Korea. astrix001@gmail.com
유리체강 내 덱사메타손 임플란트 삽입 후 발생한 망막출혈 1예
김민환⋅이영훈
건양대학교 의과대학 안과학교실
Abstract
PURPOSE
To report a case of retinal hemorrhage after a dexamethasone (Ozurdex®, Allergan, Irvine, CA, USA) intravitreal implant injection in macular edema (ME) secondary to central retinal vein occlusion (CRVO). CASE SUMMARY: A 60-year-old woman visited our hospital for ME secondary to CRVO in the right eye. Intravitreal bevacizumab injection and vitrectomy was conducted three times, but ME did not improve. Then, dexamethasone intravitreal implant was injected without any problems. Right after the dexamethasone intravitreal implant injection, retinal hemorrhage (2 disc diopter size) was observed in the infero-temporal area on fundus examination. Retinal hemorrhage completely disappeared 1 month after injection without other treatment. CONCLUSIONS: A case of dexamethasone intravitreal implant associated with retinal hemorrhage has not been previously reported in Korea. Althrough retinal hemorrhage was observed, it resolved spontaneously without treatment.
Key Words: Dexamethasone intravitreal implant;Ozurdex®;Retinal hemorrhage


ABOUT
BROWSE ARTICLES
EDITORIAL POLICY
FOR CONTRIBUTORS
Editorial Office
SKY 1004 Building #701
50-1 Jungnim-ro, Jung-gu, Seoul 04508, Korea
Tel: +82-2-583-6520    Fax: +82-2-583-6521    E-mail: kos08@ophthalmology.org                

Copyright © 2024 by Korean Ophthalmological Society.

Developed in M2PI

Close layer
prev next